StockData
Hinge Health, Inc. logo

Hinge Health, Inc. (HNGE) company profile

HNGENYSEServices-Computer Processing & Data PreparationFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/30
$114.53+0.12 (+0.10%)

Close on Nov 18, 2026Market cap $9.24BP/E –Yield –

About Hinge Health

Services-Computer Processing & Data Preparation, SIC 7374

Hinge Health operates a digital healthcare technology platform designed to automate and scale care for joint and muscle conditions. The company provides personalized care across the musculoskeletal health continuum, including injury prevention, acute pain management, chronic condition therapy, and pre- and post-surgical rehabilitation. Its platform integrates artificial intelligence-driven motion tracking, a proprietary wearable device for electrical nerve stimulation, and support from a care team of licensed physical therapists, physicians, and health coaches. The company also coordinates in-person care through a high-performance clinical provider network. Its customers primarily include self-insured employers across enterprise and public sectors, fully insured commercial health plans, Medicare Advantage populations, and federal insurance programs.

The company provides care in the United States and has expanded its international footprint to Canada, France, Germany, Ireland, the Netherlands, and the United Kingdom. It maintains research and development personnel in San Francisco, Bangalore, and Montreal. The provided text does not state the company's founding year or the specific location of its corporate headquarters.

Summary of the business section of Hinge Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Hinge Health, Inc.
Founded
2016
Headquarters
San Francisco, CA
Address
455 Market Street, 7th Floor 94105
Phone
(415) 689-8429
Employees
1,437, Dec 31, 2025
Industry
Services-Computer Processing & Data Preparation
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
DELOITTE & TOUCHE LLP, San Francisco, California

Stock & identifiers

Ticker
HNGE
Exchange
NYSE
IPO date
May 23, 2025
Shares outstanding
81M, Jul 29, 2026
Public float
$1.50B, Jun 30, 2025
Filer category
Non-accelerated filer<br>Emerging growth company
SEC CIK
1673743
CUSIP
433313103
ISIN
US4333131039
FIGI
BBG00H8V6LH4
Share class FIGI
BBG00H8V6LJ2
EIN
81-1884841

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Daniel Antonio PerezCEO & Co-Founder, Director10,534,192
James BudgeChief Financial Officer256,207
James PursleyPresident665,247
Elliott RobinsonDirector0
Gabriel M.I. MecklenburgDirector3,996,017
Tyler SloatDirector10,385
Kristina M. LeslieDirector30,387
Teddie Benjamin WardiDirector4,637

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsOtherTotalvs. prior year
Daniel Perez
Chief Executive Officer and Co-Founder
$500.00K$45.31M$7.00K$45.81M+8905%
James Budge
Chief Financial Officer
$416.67K$3.00M$27.99K$3.45M+11%
Jim Pursley
President
$500.00K$3.17M$23.99K$3.69M+31%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
May 23, 2025
Offer price
$32.00
Securities offered
13,666,000
Gross proceeds
$437.31M
Exchange
NYSE
First trading day
May 22, 2025
First-day close
$37.56+17.4%
Lock-up ends (est.)
Nov 18, 2025

“The initial public offering price per share of our Class A common stock is $32.00.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?